EPIS B — Episurf Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK102.91m
- SEK100.71m
- SEK16.10m
Annual cashflow statement for Episurf Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -69.4 | -77 | -96.7 | -77.2 | -57.9 |
| Depreciation | |||||
| Non-Cash Items | 3.3 | -0.2 | 0.7 | 1 | 0.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1 | 0.3 | 2.4 | -4.2 | -5.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -59.7 | -69.5 | -84.9 | -71.4 | -55.4 |
| Capital Expenditures | -7 | -11.3 | -9.5 | -7.6 | -6.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.5 | 0.1 | — | — | — |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.5 | -11.2 | -9.5 | -7.6 | -6.7 |
| Financing Cash Flow Items | — | — | — | -16.2 | -7.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 149 | -1.9 | -3 | 71.6 | 18.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 83 | -82.6 | -97.4 | -7.4 | -43.4 |